D. Gumurdulu Et Al. , "Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis," VIRCHOWS ARCHIV , vol.451, no.2, pp.403, 2007
Gumurdulu, D. Et Al. 2007. Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis. VIRCHOWS ARCHIV , vol.451, no.2 , 403.
Gumurdulu, D., Zeren, E. H., Guzel, B., Seydaoglu, G., Erdogan, S., Zorludemir, S., ... Vardar, M. A.(2007). Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis. VIRCHOWS ARCHIV , vol.451, no.2, 403.
Gumurdulu, DERYA Et Al. "Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis," VIRCHOWS ARCHIV , vol.451, no.2, 403, 2007
Gumurdulu, DERYA Et Al. "Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis." VIRCHOWS ARCHIV , vol.451, no.2, pp.403, 2007
Gumurdulu, D. Et Al. (2007) . "Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis." VIRCHOWS ARCHIV , vol.451, no.2, p.403.
@article{article, author={DERYA GÜMÜRDÜLÜ Et Al. }, title={Expression of survivin and topoisomerase II alpha in ovarian carcinoma: Correlation with clinicopathological parameters and prognosis}, journal={VIRCHOWS ARCHIV}, year=2007, pages={403} }